Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | RPS6KA6 |
| Upstream (Parents) |
|---|
| (<<) IFNA17 → RPS6KA6 |
| (<<) LOC222070 → RPS6KA6 |
| (<<) CD1A → RPS6KA6 |
| Downstream (Children) |
|---|
| RPS6KA6 → ROS1 (>>) |
| RPS6KA6 → GYPE///GYPB (>>) |
| RPS6KA6 → KIDINS220 (>>) |
| RPS6KA6 → CLTCL1 (>>) |
| RPS6KA6 → UBA6 (>>) |
| RPS6KA6 → PARK2 (>>) |
| RPS6KA6 → PRDM11 (>>) |
| RPS6KA6 → SRPX2 (>>) |
| RPS6KA6 → ITSN1 (>>) |
| RPS6KA6 → PHF20 (>>) |
| RPS6KA6 → FEZ2 (>>) |
| RPS6KA6 → GNAI2 (>>) |
| RPS6KA6 → LOC145678 (>>) |
| RPS6KA6 → GAK (>>) |
| RPS6KA6 → NOX5 (>>) |
| RPS6KA6 → SPAM1 (>>) |
| RPS6KA6 → EXOSC1 (>>) |
| RPS6KA6 → FGFBP1 (>>) |
| RPS6KA6 → HTR3B (>>) |
| RPS6KA6 → LOC728614 (>>) |
| RPS6KA6 → RND2 (>>) |
| RPS6KA6 → GCM2 (>>) |
| RPS6KA6 → UGT1A9///UGT1A6///UGT1A8 (>>) |
| RPS6KA6 → VDR (>>) |
| RPS6KA6 → IFNA16 (>>) |
| RPS6KA6 → NHLH2 (>>) |
| RPS6KA6 → CYP2C8 (>>) |
